These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35768027)

  • 1. Two Specialists, Two Recommendations: Discordance Between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
    Delaney RK; Sisco-Taylor BL; Wang X; Scherr K; Ubel PA; Haaland B; Kahn VC; Hamstra D; Wei JT; Madanay F; Davis JK; Greeno TU; Fagerlin A
    Urology; 2022 Nov; 169():156-161. PubMed ID: 35768027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
    BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.
    Nguyen PL; Shin H; Yousefi K; Thompson DJ; Hornberger J; Hyatt AS; Badani KK; Morgan TM; Feng FY
    Urology; 2015 Jul; 86(1):35-40. PubMed ID: 26142578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?
    Kishan AU; Duchesne G; Wang PC; Rwigema JM; Saigal C; Rettig M; Steinberg ML; King CR
    Am J Clin Oncol; 2018 Jun; 41(6):549-557. PubMed ID: 27560157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urologists' referral and radiation oncologists' treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis.
    Egger S; Smith DP; Brown BB; Kneebone AB; Dominello A; Brooks AJ; Young J; Xhilaga M; Haines M; O'Connell DL
    J Med Imaging Radiat Oncol; 2020 Feb; 64(1):134-143. PubMed ID: 31793211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
    Kim SP; Tilburt JC; Karnes RJ; Ziegenfuss JY; Han LC; Shah ND; Frank I; Smaldone MC; Gross CP; Yu JB; Trinh QD; Sun M; O'Malley RL; Nguyen PL
    Urology; 2013 Oct; 82(4):807-12. PubMed ID: 23910088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
    Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Care Related to Post-Operative Radiotherapy for Patients with Prostate Cancer among Canadian Radiation Oncologists and Urologists.
    Bristow B; Aldehaim M; Bonin K; Lam CCK; Wan SJ; Cao X; Szumacher E
    J Cancer Educ; 2018 Dec; 33(6):1195-1200. PubMed ID: 28573519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician visits prior to treatment for clinically localized prostate cancer.
    Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
    Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
    Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
    Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
    J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions.
    Han LC; Delpe S; Shah ND; Ziegenfuss JY; Tilburt JC; Karnes RJ; Nguyen PL; Gross CP; Yu JB; Trinh QD; Sun M; Ranasinghe WK; Kim SP
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):277-83. PubMed ID: 24685153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.
    Lavallée LT; Fergusson D; Mallick R; Grenon R; Morgan SC; Momoli F; Witiuk K; Morash C; Cagiannos I; Breau RH
    PLoS One; 2013; 8(11):e79773. PubMed ID: 24224003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.
    Sylvester J; Grimm P; Blasco J; Meier R; Spiegel J; Heaney C; Cavanagh W
    Urology; 2001 Aug; 58(2 Suppl 1):65-70. PubMed ID: 11502452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in content discussed by specialty in consultations for clinically localized prostate cancer.
    Friedrich NA; Luu M; Gale R; Chaplin A; Ballas L; Sandler HM; Posadas EM; Freedland SJ; Spiegel B; Kokorowski P; Daskivich TJ
    Urol Oncol; 2024 Sep; 42(9):288.e7-288.e15. PubMed ID: 38762384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.